MDL 17,043 therapy in severe congestive heart failure: Characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response
Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure
Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy
Syntheses and Absolute Stereochemistries of UPA0043 and UPA0044, Cytotoxic Antibiotics Having ap-Quinone-methide Structure
Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial
O-043. Investigations of meiotic chromosome pairing in human oocytes by sequential light microscopy immunocytogenetics, FISH and transmission electron microscopy
al-Zuḫruf - الزخرف - 043
